Hypaque-Cysto is a radiopaque contrast agent formulated specifically for retrograde cystourethrography—the fluoroscopic study that outlines the urinary bladder, bladder neck, urethra, and (when reflux is present) the distal ureters. The agent is diatrizoate meglumine, an ionic, water-soluble, tri-iodinated benzoate salt supplied as a sterile solution that can be used as-is or diluted to lower concentrations. Because it stays within the bladder when instilled and is minimally absorbed through intact urothelium, it produces crisp outlines with limited systemic exposure. Clinically, its strengths are reliability, flexible dilution, and wide availability across adult and pediatric imaging. Its risks are familiar to contrast users: avoid intrathecal or intravascular administration, monitor for rare hypersensitivity, and respect osmolality—especially in children or inflamed bladders. This guide translates the label and radiology practice standards into clear, step-by-step instructions for safe, effective use.
Quick Overview
- Indicated for retrograde cystourethrography to assess reflux, bladder injury, fistula, diverticula, and outlet function.
- Typical working range: 10–30% solution, instilled 200–300 mL in adults (pediatrics: capacity-based).
- Never administer intrathecally or intravascularly; use gentle, gravity-assisted filling without force.
- Avoid in patients with prior severe reaction to iodinated contrast; use caution with active UTI or recent surgery.
Table of Contents
- What is Hypaque-Cysto and how it works
- When to use it and what it shows
- How to prepare and administer (step by step)
- Choosing concentration and volume
- Side effects, precautions, and who should avoid
- Evidence, standards, and checklists
What is Hypaque-Cysto and how it works
Hypaque-Cysto is the brand name for a 30% sterile aqueous solution of diatrizoate meglumine formulated for retrograde cystourethrography. Diatrizoate is an ionic, water-soluble iodinated anion paired with a radiolucent cation (meglumine). Each milliliter of the 30% solution contains approximately 141 mg of organically bound iodine. The fluid is hypertonic relative to plasma and can be diluted with sterile water or 5% dextrose to achieve lower, procedure-appropriate concentrations.
The physics are straightforward: iodine attenuates x-rays. When Hypaque-Cysto fills the bladder lumen, the column of contrast outlines mucosa, trabeculations, diverticula, and surgical alterations. During voiding (voiding cystourethrography, VCUG), dynamic fluoroscopy captures the bladder neck opening, urethral contour, and any retrograde flow into ureters—key for grading vesicoureteral reflux. Because the agent stays within the lower urinary tract when instilled retrograde, systemic exposure is low; however, pyelovenous or lymphatic intravasation can occur if reflux is present or if pressure is excessive. That is why the technique emphasizes gentle filling and avoidance of force.
Chemically, Hypaque-Cysto is relatively thermostable and formulated without preservative; it includes a trace chelating stabilizer (edetate). The solution’s viscosity is low enough for gravity infusion through standard pediatric and adult urethral catheters. Osmolality and ionic character contribute to image quality but also to potential irritation: higher concentrations visualize fine anatomy at the cost of more bladder sensation; lower concentrations are gentler but may require careful exposure technique and collimation.
Importantly, this product is not for intrathecal use and not for intravascular injection. Those routes have distinct agents, concentrations, and safety profiles. In cystography, correct route and pressure management keep the procedure safe. When used as labeled, adverse systemic effects are rare; most issues arise from over-distention, infection, or inadvertent vascular entry in the presence of reflux.
In daily practice, consider Hypaque-Cysto the workhorse agent for fluoroscopic cystography and VCUG: predictable, easy to dilute, and time-tested across indications—from pediatric reflux to postoperative leak checks—when handled with sterile technique and conservative filling.
When to use it and what it shows
Indications where Hypaque-Cysto adds decisive value
- Vesicoureteral reflux (VUR): In children with recurrent UTIs or abnormal renal ultrasound, VCUG remains the reference fluoroscopic test to detect and grade reflux. Contrast reaching ureters or renal pelvis during filling or voiding confirms VUR and helps risk-stratify management.
- Bladder or urethral injury: After pelvic trauma, urologic surgery, or difficult catheterization, cystography/VCUG demonstrates extravasation sites, anastomotic integrity, and urethral disruptions.
- Fistulas and diverticula: Outpouchings (diverticula), vesicovaginal or vesicointestinal fistulas, and ureteroceles are delineated by the column of contrast.
- Outlet obstruction and dysfunction: During voiding images, the bladder neck and urethra can be evaluated for strictures, valves (in infants), or dysfunctional voiding patterns.
- Postoperative surveillance: After bladder repair (e.g., post-cesarean bladder injury repair) or augmentation cystoplasty, cystography confirms healing before catheter removal.
What the images can answer in one session
- Anatomy: Capacity, wall trabeculation, diverticula, ureteral orifices, post-surgical anatomy.
- Function: Detrusor contractions, coordinated opening of bladder neck, residual contrast post-void.
- Reflux behavior: Whether reflux occurs on filling or voiding, its laterality and grade, and whether it reaches the renal pelvis.
- Leak dynamics: Whether there is intraperitoneal or extraperitoneal extravasation and how it changes with pressure or voiding.
Strengths compared with alternatives
- Fluoroscopic cystography/VCUG is fast, widely available, and allows graded, real-time filling—safer than one-shot, high-pressure instillation.
- CT cystography excels for trauma when simultaneous evaluation of pelvic bones and other organs is needed; it typically uses dilute iodinated contrast but involves higher radiation.
- Ultrasound can suggest reflux (Doppler “ureteral jets”) and wall changes but lacks the sensitivity and dynamic detail of contrast cystography.
- Radionuclide cystography offers low radiation for follow-up reflux screening but with lower spatial resolution.
Who benefits most
- Children with suspected VUR after febrile UTI or abnormal renal ultrasound.
- Post-surgical patients where confirming watertight repair averts premature catheter removal.
- Trauma patients with hematuria or suspected lower tract injury.
- Adults with recurrent UTIs, fistulas, or suspected outlet dysfunction not resolved by cystoscopy alone.
When to defer or choose an alternative
- Uncontrolled UTI with fever or severe dysuria: treat infection first; avoid provoking bacteremia or worsening symptoms.
- Immediate postoperative settings with tenuous anastomoses: coordinate with the surgeon for timing and pressure limits.
- Severe iodinated contrast reactions in history: consider non-iodinated approaches (e.g., radionuclide cystography) or specialist-directed alternatives.
Used for the right questions—reflux, leaks, fistulas, and outlet mechanics—Hypaque-Cysto produces high-value answers quickly, guiding surgery, antibiotics, and follow-up with minimal systemic exposure.
How to prepare and administer (step by step)
1) Pre-procedure planning
- Confirm indication and recent labs/imaging. Clarify the clinical question (reflux grading, leak check, fistula map).
- Screen for contraindications/cautions. Prior severe reaction to iodinated contrast, active UTI with fever, recent pelvic surgery, pregnancy, and urethral trauma change technique or timing.
- Consent and explain. Describe catheter placement, filling sensations, and the need to void on the table for VCUG.
- Equipment. Fluoroscopy suite; sterile tray; appropriate urethral catheter (feeding tube in infants); Hypaque-Cysto; sterile water or D5W for dilution; collection bag; contrast bottle with calibrated markings; pressure bag not used—gravity only.
2) Prepare the contrast
- Choose starting concentration (see next section). Many labs begin at 10–20% for pediatric reflux studies and 15–30% for adult leak checks or complex anatomy.
- Dilute aseptically using sterile water or 5% dextrose. Label final concentration and volume. Inspect for clarity; discard if discolored or contaminated.
- Warm to room temperature to reduce viscosity and patient discomfort.
3) Catheterize under sterile technique
- Position and prep per institutional policy; use topical anesthetic gel as appropriate.
- Catheter size: infant feeding tube (4–6 Fr) for infants; 6–8 Fr pediatric; 10–14 Fr adult female; 12–16 Fr adult male depending on anatomy.
- Secure the catheter to prevent displacement during voiding images (avoid balloon over-inflation; the aim is stability, not occlusion).
4) Fill the bladder—slow and gentle
- Gravity infusion with the contrast bottle below 60 cm above the table; avoid syringes used to forcibly push contrast.
- Coaching: proceed beyond first desire to void but stop at urgency or mild discomfort. Over-distention elevates leak risk and provokes reflux artifact.
- Monitor continuously under low-dose fluoroscopy or intermittent spot images to track bladder contour, ureteral orifices, and distal ureters.
5) Acquire diagnostic sequences
- Filling phase: frontal and oblique views of the bladder and urethra; document any spontaneous reflux.
- Voiding phase (VCUG): remove catheter if protocol requires; capture bladder neck opening and urethral contour during micturition.
- Post-void images: assess residual contrast and delayed reflux.
6) Volumes and endpoints
- Adults: typical capacity 200–300 mL (rarely up to 600 mL). In pathology, capacity may be as low as 50 mL or over 1,000 mL—use symptoms and fluoroscopic feedback, not fixed targets.
- Infants: capacity 20–50 mL at birth; approximately quadruples in the first year.
- Children 3–5 years: 150–180 mL; >8 years: low adult range.
7) Post-procedure care
- Encourage hydration to dilute residual contrast.
- Advise patients to expect transient urgency or mild dysuria.
- Provide return precautions (fever, persistent hematuria, severe pain).
8) Documentation
- Final concentration, total instilled volume, patient tolerance, reflux grade (if present), leak location and extent, and any complications.
- Record contrast lot number, expiration, and catheter size.
Done well, the procedure feels controlled and comfortable, yields decisive images, and avoids pressure-related artifacts or complications.
Choosing concentration and volume
The art of cystography is matching concentration and volume to the question at hand, the patient’s age, and bladder condition.
Concentration basics
- Stock solution: Hypaque-Cysto 30% (≈ 141 mg iodine/mL).
- Isotonic point: about 10%; lower osmolality solutions are gentler for inflamed bladders and pediatrics.
- Common working ranges:
- Pediatrics/VCUG for VUR: 10–15% is typical; it reduces irritation and curbs pressure-driven reflux artifacts.
- Adult leak checks or complex anatomy: 15–25% offers crisper margins to localize small extravasations or fistulas.
- High-detail mucosal mapping: 20–30% can outline diverticula or urethral pathology when irritation is acceptable and filling is cautious.
Label-based dilution examples (from a 500 mL bottle containing 250 mL of 30%)
- Add 50 mL sterile water → 300 mL at 25% (≈ 118 mg iodine/mL).
- Add 150 mL sterile water → 400 mL at 18.8% (≈ 88 mg iodine/mL).
- Add 250 mL sterile water → 500 mL at 15% (≈ 71 mg iodine/mL).
- To make 10%, remove contrast and adjust per the bottle’s dilution table to reach 450 mL total with ≈47 mg iodine/mL.
Volume strategy
- Adults: plan for 200–300 mL, but stop at urgency or pain; higher volumes are acceptable in atonic bladders if clinically justified.
- Infants and small children: use predicted capacity formulas or age tables, then titrate to comfort and fluoroscopic endpoints.
- Postoperative leak checks: smaller, incremental fills (e.g., 50–100 mL steps) can localize the leak threshold without stressing the repair.
Scenario playbook
- Child with febrile UTI, first VCUG: Start 10–12%, gravity fill, capture filling and voiding. If no reflux and image quality is marginal, cautiously increase concentration at a repeat study only if needed.
- Adult after bladder repair: Begin 15–20%, fill in 50–100 mL increments under fluoroscopy to identify any early oozing or frank extravasation; stop at the first sign of leak.
- Suspected vesicovaginal fistula: 20–25% improves fistula conspicuity; use gentle filling and targeted obliques, with padding to separate compartments.
- Urethral stricture evaluation: Voiding images are key; catheter size and removal timing matter as much as concentration (often 15–20% is sufficient).
Technique pearls that matter more than numbers
- Gravity over pressure. Hang the bottle modestly above the patient—avoid syringes used to “push” contrast.
- Stop at symptoms. Urgency or discomfort is your safety signal.
- Record the recipe. Document concentration and total volume so future studies reproduce what worked.
Choosing the right concentration and volume is less about hitting a textbook number and more about tailoring to the indication, patient comfort, and dynamic fluoroscopic feedback.
Side effects, precautions, and who should avoid
Typical, self-limited effects
- Bladder sensations: warmth, urgency, transient dysuria after the study.
- Mild hematuria: usually resolves within 24 hours, particularly after catheterization in sensitive urethras.
- Vasovagal symptoms: lightheadedness or nausea with anxiety; pause, lower the bottle, and reassure.
Serious risks (uncommon but important)
- Inadvertent intravascular entry: possible via pyelovenous routes in significant reflux or mucosal disruption. Systemic reactions can occur; maintain gentle filling and close observation.
- Allergic-like reactions to iodinated contrast: rare with intravesical use but possible; have emergency medications and trained staff available.
- Over-distention injury or extravasation: pain, spasm, or tear with forceful instillation—avoid by using gravity and honoring patient feedback.
- Infection: catheterization can seed or exacerbate UTI; use strict sterile technique and defer in febrile infections when feasible.
Strict do-not-dos
- Never intrathecal. Severe neurologic injury and death have followed intrathecal administration of non-approved iodinated agents.
- Not for intravascular injection. This formulation and concentration are not intended for vascular use.
- Do not force. Avoid pressure syringes and do not exceed patient-tolerated volumes.
Drug and lab test considerations
- Mixture incompatibilities: certain antihistamines (e.g., diphenhydramine) can precipitate if mixed in the same syringe—keep lines separate.
- Thyroid tests: iodinated contrast can transiently alter iodine-based assays; schedule such tests before the study or allow a washout period if clinically relevant.
- Coagulation and platelet assays: transient effects have been reported after intravascular exposure; the risk is minimal with intravesical use, but it’s prudent to document timing if labs are imminent.
Who should avoid or delay
- Active febrile UTI or untreated urethritis/cystitis—treat first.
- Recent pelvic or bladder surgery where pressure could jeopardize repair—coordinate with the surgical team for timing and volume limits.
- History of severe immediate hypersensitivity to iodinated contrast—consider alternative modalities or premedication protocols under specialist guidance.
- Pregnancy: diagnostic cystography includes radiation; balance risks and benefits carefully.
- Unstable patients or those with suspected urethral transection—use tailored trauma protocols.
Practical safety checklist
- Resuscitation equipment and trained personnel immediately available.
- Verify route and indication aloud: “Intravesical, not IV, not intrathecal.”
- Use gravity fill; set bottle height conservatively.
- Stop at urgency; do not chase “perfect capacity” at the expense of safety.
- Document concentration, total volume, and patient response.
Most adverse events are preventable with meticulous technique and respect for pressure, route, and patient feedback.
Evidence, standards, and checklists
What underpins current practice
- Product labeling sets the foundation: Hypaque-Cysto is indicated for retrograde cystourethrography in adults and children; it provides capacity guidance (typical adult 200–300 mL, pediatric age-based), dilution tables (e.g., 25%, 18.8%, 15%, and 10%), and explicit route warnings (not intrathecal, not intravascular).
- Professional guidelines from radiology societies outline patient selection, equipment, documentation, radiation safety, and infection control for adult cystography and urethrography. These parameters standardize technique (gravity filling, gentle distention, dynamic imaging) and reporting (e.g., reflux grade, leak location).
- Contrast media manuals summarize evidence on contrast reactions, preparation, and special populations, reinforcing label cautions and providing institutional policies on emergency readiness, informed consent, and post-procedure monitoring.
Why ionic, water-soluble diatrizoate remains relevant
- Predictable image quality at low to moderate concentrations.
- Flexible dilution to balance conspicuity and comfort across ages and indications.
- Minimal systemic absorption with intravesical use, supporting safety when technique is correct.
Where practice is evolving
- Radiation stewardship: pulse rates, collimation, and last-image hold continually improve dose metrics in pediatric VCUG.
- Alternative imaging in special cases: for severe prior reactions to iodinated contrast, centers may consider radionuclide cystography or expert-directed alternatives in rare scenarios.
- CT cystography has expanded for trauma pathways; it uses dilute iodinated contrast through the catheter with helical acquisition and delayed images to map intraperitoneal versus extraperitoneal leaks.
A concise pre-study checklist
- Indication confirmed and timing appropriate.
- Allergy and infection screens completed; pregnancy status addressed when relevant.
- Contrast recipe written (target % and planned mL range).
- Equipment prepared; gravity setup verified (no pressure bag).
- Staff roles assigned for filling, imaging, and documentation.
- Stop criteria rehearsed (urgency, pain, leak visualization).
- Post-study hydration and return precautions given.
A concise post-study report template
- Contrast type, final concentration, and total instilled volume.
- Bladder capacity and wall features; diverticula or trabeculations.
- Reflux: side(s), phase (filling or voiding), and grade.
- Urethral findings on voiding (stricture, valves, sphincter dynamics).
- Leak presence, location, size, and change with filling; whether intraperitoneal or extraperitoneal by imaging signs.
- Complications or early termination and reason.
By aligning label specifics with professional standards and thoughtful checklists, teams produce high-quality, reproducible studies that answer the clinical question while minimizing discomfort and risk.
References
- HYPAQUE – CYSTO- diatrizoate meglumine injection, solution 2016 (Label)
- CYSTOGRAFIN- diatrizoate meglumine injection, solution 2018 (Label)
- Manual on Contrast Media 2025 (Guidance)
- ACR–SAR PRACTICE PARAMETER FOR THE PERFORMANCE OF ADULT CYSTOGRAPHY AND URETHROGRAPHY 2023 (Practice Parameter)
Disclaimer
This article is educational and does not replace professional medical advice, diagnosis, or treatment. Contrast studies should be performed only by trained clinicians using current product labeling and institutional protocols. If you have questions about the need for cystography, potential risks, or alternatives, discuss them with your radiologist or urologist. If you experience severe pain, fever, rash, breathing difficulty, or persistent hematuria after a study, seek medical care promptly.
If you found this guide helpful, please consider sharing it on Facebook, X (formerly Twitter), or your preferred platform, and follow us for future evidence-based explainers. Your support helps us continue producing high-quality content.
